Discovery of Antibody based molecules for Pretargeted Radio Immune Therapy
PRODUCTS
Cutting-edge Antibody Tehchnology Solutions
Lab Research
Through comprehensive antibody characterization both in-silco and real lab data we assess developability and manufacturability of our candidate molecules to mitigate smooth transition to later production and handling phases
Product Discovery
We specialize in developing groundbreaking antibody based molecules for PRIT in cancer. We provide specialized bispecific formats that bind a selection of chelator-metal complexes and tumor targets.
Propietary candidates
We are building a pipeline of propietary molecules for the use in PRIT based cancer therapy. Molecules will be available for licensing or acuisition.
GET IN TOUCH